BACKGROUND: Skin melanocytes can give rise to benign and malignant neoplasms. Discrimination of an early melanoma from an unusual/atypical benign nevus can represent a significant challenge. However, previous studies have shown that in contrast to benign nevi, melanoma demonstrates pervasive chromosomal aberrations. OBJECTIVE: This substantial difference between melanoma and benign nevi can be exploited to discriminate between melanoma and benign nevi. METHODS: Array-comparative genomic hybridization (aCGH) is an approach that can be used on DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissues to assess the entire genome for the presence of changes in DNA copy number. In this study, high resolution, genome-wide single-nucleoti...
SummaryThe melanoma genome possesses numerous recurrent chromosomal rearrangements, and embedded wit...
Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and cl...
Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and cl...
BACKGROUND: Skin melanocytes can give rise to benign and malignant neoplasms. Discrimination of an e...
BACKGROUND: Skin melanocytes can give rise to benign and malignant neoplasms. Discrimination of an e...
BACKGROUND: Skin melanocytes can give rise to benign and malignant neoplasms. Discrimination of an e...
Skin melanocytes can give rise to different benign and malignant neoplasms. Discrimination of an ear...
Recent evidence indicates that melanoma comprises distinct types of tumors and suggests that specifi...
Recent evidence indicates that melanoma comprises distinct types of tumors and suggests that specifi...
Recent evidence indicates that melanoma comprises distinct types of tumors and suggests that specifi...
Cutaneous intermediate melanocytic neoplasms with ambiguous histopathological features are diagnosti...
Cutaneous intermediate melanocytic neoplasms with ambiguous histopathological features are diagnosti...
Cutaneous intermediate melanocytic neoplasms with ambiguous histopathological features are diagnosti...
Thanks to a never-before detailed view of the human genome, the last decade has brought to light the...
Although a number of genes related to melanoma development have been identified through candidate ge...
SummaryThe melanoma genome possesses numerous recurrent chromosomal rearrangements, and embedded wit...
Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and cl...
Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and cl...
BACKGROUND: Skin melanocytes can give rise to benign and malignant neoplasms. Discrimination of an e...
BACKGROUND: Skin melanocytes can give rise to benign and malignant neoplasms. Discrimination of an e...
BACKGROUND: Skin melanocytes can give rise to benign and malignant neoplasms. Discrimination of an e...
Skin melanocytes can give rise to different benign and malignant neoplasms. Discrimination of an ear...
Recent evidence indicates that melanoma comprises distinct types of tumors and suggests that specifi...
Recent evidence indicates that melanoma comprises distinct types of tumors and suggests that specifi...
Recent evidence indicates that melanoma comprises distinct types of tumors and suggests that specifi...
Cutaneous intermediate melanocytic neoplasms with ambiguous histopathological features are diagnosti...
Cutaneous intermediate melanocytic neoplasms with ambiguous histopathological features are diagnosti...
Cutaneous intermediate melanocytic neoplasms with ambiguous histopathological features are diagnosti...
Thanks to a never-before detailed view of the human genome, the last decade has brought to light the...
Although a number of genes related to melanoma development have been identified through candidate ge...
SummaryThe melanoma genome possesses numerous recurrent chromosomal rearrangements, and embedded wit...
Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and cl...
Malignant melanoma is an aggressive, heterogeneous disease where new biomarkers for diagnosis and cl...